OSELTAMIVIR PHOSPHATE
- Product NDC
- 69315-174
- 11-digit product format
- 693150174
- Labeler code
- 69315
- Product ID
- 69315-174_473d55b2-bec6-4f76-b5a2-275431b2eb09
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OSELTAMIVIR PHOSPHATE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Leading Pharma, LLC
- Application
- ANDA214949
- Marketing category
- ANDA
- Marketing start
- 2022-06-01
- Substance
- OSELTAMIVIR PHOSPHATE
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OSELTAMIVIR PHOSPHATE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OSELTAMIVIR PHOSPHATE | 6 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4A3O49NGEZ |
| Rxcui | 1115698 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69315-174-60 | OSELTAMIVIR PHOSPHATE | 60 mL in 1 BOTTLE | SUSPENSION | 60 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69315-174 | OSELTAMIVIR PHOSPHATE SUSPENSION [LEADING PHARMA, LLC] | 8 | Current NDC, Legacy NDC, 1 package rows | 20241009_ef093e4d-5b1a-463f-a1a3-b795a4387a81.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69315-174-60 | 69315017460 | 60 mL in 1 BOTTLE (69315-174-60) | 60 ml | 2022-06-01 | 0000-00-00 | No | No | Current |